4DMedical FDMDF Stock
4DMedical Price Chart
4DMedical FDMDF Financial and Trading Overview
| 4DMedical stock price | 3 USD |
| Previous Close | 2.75 USD |
| Open | 3 USD |
| Bid | 2.11 USD x 30000 |
| Ask | 3.1 USD x 220000 |
| Day's Range | 3 - 3 USD |
| 52 Week Range | 0.87 - 5 USD |
| Volume | 1K USD |
| Avg. Volume | 645 USD |
| Market Cap | 1.8B USD |
| Beta (5Y Monthly) | 1.949 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.26 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
FDMDF Valuation Measures
| Enterprise Value | 1.71B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 255.57762 |
| Price/Book (mrq) | 15.018928 |
| Enterprise Value/Revenue | 241.732 |
| Enterprise Value/EBITDA | -30.473 |
Trading Information
4DMedical Stock Price History
| Beta (5Y Monthly) | 1.949 |
| 52-Week Change | 109.79% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 5 USD |
| 52 Week Low | 0.87 USD |
| 50-Day Moving Average | 2.74 USD |
| 200-Day Moving Average | 2.82 USD |
FDMDF Share Statistics
| Avg. Volume (3 month) | 645 USD |
| Avg. Daily Volume (10-Days) | 200 USD |
| Shares Outstanding | 601.59M |
| Float | 498.92M |
| Short Ratio | N/A |
| % Held by Insiders | 16.59% |
| % Held by Institutions | 23.84% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -735.057% |
| Gross Margin | 93.76% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.60% |
| Return on Equity (ttm) | -174.43% |
Income Statement
| Revenue (ttm) | 7.06M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | 42.29% |
| Gross Profit (ttm) | 6.62M USD |
| EBITDA | -56016108 USD |
| Net Income Avi to Common (ttm) | -204435904 USD |
| Diluted EPS (ttm) | -0.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 277.95M USD |
| Total Cash Per Share (mrq) | 0.46 USD |
| Total Debt (mrq) | 180.24M USD |
| Total Debt/Equity (mrq) | 105.92 USD |
| Current Ratio (mrq) | 30.792 |
| Book Value Per Share (mrq) | 0.19974795 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31274940 USD |
| Levered Free Cash Flow (ttm) | -136017808 USD |
Profile of 4DMedical
| Country | United States |
| State | VIC |
| City | Carlton |
| Address | Melbourne Connect |
| ZIP | 3053 |
| Phone | 61 3 9545 5940 |
| Website | https://4dmedical.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 181 |
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in medical research technology and development of a non invasive respiratory imaging solution. It offers CT:VQ, non-contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company has partnership with AstraZeneca to launch and expand a lung health screening program; and a contractual engagement with GlaxoSmithKline to provide its proprietary quantitative lung imaging analytics in support of pulmonary drug development and clinical research. 4DMedical Limited was incorporated in 2012 and is based in Carlton, Australia.
Q&A For 4DMedical Stock
What is a current FDMDF stock price?
4DMedical FDMDF stock price today per share is 3 USD.
How to purchase 4DMedical stock?
You can buy FDMDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 4DMedical?
The stock symbol or ticker of 4DMedical is FDMDF.
Which industry does the 4DMedical company belong to?
The 4DMedical industry is Medical Devices.
How many shares does 4DMedical have in circulation?
The max supply of 4DMedical shares is 601.59M.
What is 4DMedical Price to Earnings Ratio (PE Ratio)?
4DMedical PE Ratio is now.
What was 4DMedical earnings per share over the trailing 12 months (TTM)?
4DMedical EPS is -0.26 USD over the trailing 12 months.
Which sector does the 4DMedical company belong to?
The 4DMedical sector is Healthcare.
